Lepu Medical Technology Co., Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.
October 25, 2023 at 11:26 am
Share
Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) announces a share repurchase program. Under the program, the company will repurchase up to CNY 500 million worth of shares. The repurchase price will not be more than CNY 25 per share. Shares repurchased will be used for ESOP or equity incentives. The program will be valid till 12 months.
On June 19, 2024, the company adjusted its upper limit on shares repurchase price after the implementation of equity distribution. The company has adjusted repurchase price to CNY 24.67 per share.
Lepu Medical Technology (Beijing) Co., Ltd. specialized in the design, manufacture and marketing of medical devices and equipment. The group is also involved in the development and manufacturing of active pharmaceutical ingredients. Net sales break down by activity as follows:
- sale of medical devices and instruments (57.9%): primarily for cardiovascular interventions, cardiac surgery, cardiac rhythm management, anesthesia, intensive care, in vitro diagnostics and general surgery;
- sale of active pharmaceutical ingredients (30.6%): for the manufacturing of pharmaceutical products in the fields of cardiovascular diseases, infectious diseases, oncology, central nervous system disorders, etc.;
- sale of digital health and hospital network management solutions (11.6%).
China accounts for 64.7% of net sales.
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 
